Business Description
Getinge AB
ISIN : SE0000202624
Share Class Description:
MEX:GETIB: Class BCompare
Compare
Traded in other countries / regions
GETI B.Sweden0GZV.UKGNGBY.USAGTN.GermanyGETIB.Mexico IPO Date
2020-12-08Description
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (34%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.27 | |||||
| Equity-to-Asset | 0.57 | |||||
| Debt-to-Equity | 0.27 | |||||
| Debt-to-EBITDA | 1.37 | |||||
| Interest Coverage | 9.68 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 2.84 | |||||
| Beneish M-Score | -2.59 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 2.2 | |||||
| 3-Year EBITDA Growth Rate | -6.4 | |||||
| 3-Year EPS without NRI Growth Rate | -8.5 | |||||
| 3-Year FCF Growth Rate | -36.1 | |||||
| 3-Year Book Growth Rate | 12.8 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 12.37 | |||||
| Future 3-5Y Total Revenue Growth Rate | 5.15 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.15 | |||||
| Quick Ratio | 0.65 | |||||
| Cash Ratio | 0.16 | |||||
| Days Inventory | 143.54 | |||||
| Days Sales Outstanding | 53.87 | |||||
| Days Payable | 45.92 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Dividend Growth Rate | 41.5 | |||||
| Shareholder Yield % | -1.32 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 46.27 | |||||
| Operating Margin % | 13.48 | |||||
| Net Margin % | 7.75 | |||||
| FCF Margin % | 9.69 | |||||
| ROE % | 8.24 | |||||
| ROA % | 4.76 | |||||
| ROIC % | 6.79 | |||||
| ROC (Joel Greenblatt) % | 56.63 | |||||
| ROCE % | 9.72 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 22.09 | |||||
| Forward PE Ratio | 47.32 | |||||
| PE Ratio without NRI | 20.41 | |||||
| Shiller PE Ratio | 26.41 | |||||
| Price-to-Owner-Earnings | 17.27 | |||||
| PEG Ratio | 0.92 | |||||
| PS Ratio | 1.71 | |||||
| PB Ratio | 1.81 | |||||
| Price-to-Free-Cash-Flow | 17.41 | |||||
| Price-to-Operating-Cash-Flow | 12.43 | |||||
| EV-to-EBIT | 15.2 | |||||
| EV-to-EBITDA | 10.04 | |||||
| EV-to-Revenue | 1.89 | |||||
| EV-to-FCF | 19.34 | |||||
| Price-to-Projected-FCF | 1.01 | |||||
| Price-to-Median-PS-Value | 1.09 | |||||
| Price-to-Peter-Lynch-Fair-Value | 3.13 | |||||
| Earnings Yield (Greenblatt) % | 6.58 | |||||
| FCF Yield % | 5.77 | |||||
| Forward Rate of Return (Yacktman) % | 12.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Getinge AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil MXN) | 54,985.128 | ||
| EPS (TTM) (MXN) | 15.53 | ||
| Beta | 0 | ||
| Volatility % | 0.77 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (MXN) | 0 | ||
| 20-Day SMA (MXN) | 901.62 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (MXN) | 901.62 - 901.62 | ||
| Shares Outstanding (Mil) | 272.37 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Getinge AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Getinge AB Stock Events
| Event | Date | Price(MXN) | ||
|---|---|---|---|---|
| No Event Data | ||||
Getinge AB Frequently Asked Questions
What is Getinge AB(MEX:GETIB)'s stock price today?
The current price of MEX:GETIB is MXN901.62. The 52 week high of MEX:GETIB is MXN901.62 and 52 week low is MXN901.62.
When is next earnings date of Getinge AB(MEX:GETIB)?
The next earnings date of Getinge AB(MEX:GETIB) is 2024-10-18.
Does Getinge AB(MEX:GETIB) pay dividends? If so, how much?
Getinge AB(MEX:GETIB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers